825
Views
29
CrossRef citations to date
0
Altmetric
Biochemistry & Molecular Biology

miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway

, , &
Pages 119-126 | Received 25 Apr 2016, Accepted 08 Sep 2016, Published online: 12 Oct 2016

Figures & data

Fig. 1. Expression of miR-30 in GC tissues and cell lines.

Notes: (A) Relative expression of miR-30 in all tissue samples of GC and normal tissues. (B) Relative expression of miR-30 in GES-1, HGC-27, MKN-28, MKN-45, MGC-803, SGC-7901 cell lines. Results were shown as the mean ± SEM. *Indicated statistical significance (p < 0.05) compared with respective control.
Fig. 1. Expression of miR-30 in GC tissues and cell lines.

Fig. 2. Effect of up- and down-regulation of miR-30 on cell proliferation and apoptosis in HGC-27 cells.

Notes: HGC-27 cells were transfected with miR-30 inhibitors or mimics. (A and C) Efficiency of inhibition or overexpression of miR-30 expression was examined by real-time PCR. Relative expression of miR-30 was shown as folds of control. (B and D) Cell proliferation was measured by an assay kit and cell growth curve was shown. (C and E) Apoptotic cell death was measured using TUNEL staining and results were shown as folds of control. Results were shown as the mean ± SEM. *Indicated statistical significance (p < 0.05) compared with respective control.
Fig. 2. Effect of up- and down-regulation of miR-30 on cell proliferation and apoptosis in HGC-27 cells.

Fig. 3. Role of P53 in the effect of down-regulation of miR-30 on cell proliferation and apoptosis in HGC-27 cells.

Notes: (A) Relative expression of P53 in all tissue samples of GC and normal tissues. (B) Correlation of the expression of miR-30 and P53 in GC tissues. HGC-27 cells were transfected with miR-30 inhibitors. mRNA (C) and protein (D) expression of P53 was determined by real-time PCR and western blot. HGC-27 cells were transfected with shP53 lentivirus and then transfected with miR-30 inhibitors. (E) Cell proliferation was measured by an assay kit and cell growth curve was shown. (F) Apoptotic cell death was measured using TUNEL staining and results were shown as folds of control. Results were shown as the mean ± SEM. *Indicated statistical significance (p < 0.05) compared with respective control. #Indicated statistical significance (p < 0.05) compared with miR-30 inhibitor group.
Fig. 3. Role of P53 in the effect of down-regulation of miR-30 on cell proliferation and apoptosis in HGC-27 cells.

Fig. 4. Role of P53/ROS-mediated mitochondrial pathway in the effect of downregulation of miR-30 on cell proliferation and apoptosis in HGC-27 cells.

Notes: HGC-27 cells were transfected with shP53 lentivirus and then transfected with miR-30 inhibitors. (A) cells were stained with 10 μM DHE to examine ROS level. HGC-27 cells were transfected with shP53 lentivirus or pretreated with100 μM NAC, and then transfected with miR-30 inhibitors. (B) Mitochondria were isolated and oxygen consumption rate was determined using a Clark Oxygen Electrode. (C) Cytoplasmic protein was extracted and protein expression of Cyto C was determined by western blot. (D and E) Caspase 3 and 9 activities were determined using commercial kits. (F) Apoptotic cell death was measured using TUNEL staining and results were shown as folds of control. Results were shown as the mean ± SEM. *Indicated statistical significance (p < 0.05) compared with respective control. #Indicated statistical significance (p < 0.05) compared with miR-30 inhibitor group.
Fig. 4. Role of P53/ROS-mediated mitochondrial pathway in the effect of downregulation of miR-30 on cell proliferation and apoptosis in HGC-27 cells.

Fig. 5. Schematic figure of the mechanism of miR-30-mediated regulation of GC cell proliferation.

Fig. 5. Schematic figure of the mechanism of miR-30-mediated regulation of GC cell proliferation.
Supplemental material

TBBB_1238294_Supplementary_Material.docx

Download MS Word (16.4 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.